Literature DB >> 19203654

Complementary and alternative medicine for the allergist-immunologist: where do I start?

Renata J M Engler1, Catherine M With, Philip J Gregory, Jeff M Jellin.   

Abstract

Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 2007 described the most commonly used nonvitamin, nonmineral therapy as natural products (eg, herbals at 17.7%). More than 5% of children under the age of 18 years used CAM for allergic conditions including asthma. The amount and quality of information available and concerns about liability risk represent a challenge for most physicians. This review focuses on considerations for approaching a CAM-related consultation, incorporating legal and logistic factors affecting how such an encounter should be approached. A 10-step process is presented that addresses different components of CAM consultations and what should be documented. Access to timely, high-quality information regarding product specific efficacy and safety data, as found in the Natural Medicines Comprehensive Database, is needed to support CAM consultation efficiently. Understanding of serious adverse events associated with CAM is limited; an international need exists for improved safety surveillance and information sharing. Allergy-immunology, as a specialty with expertise in adverse drug reaction evaluation and management, has a unique opportunity to support enhanced CAM-related adverse events evaluations, reporting, and research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19203654      PMCID: PMC3891367          DOI: 10.1016/j.jaci.2009.01.001

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  26 in total

1.  Two cases of adrenal suppression following a Chinese herbal remedy: a cause for concern?

Authors:  C M Florkowski; P A Elder; J G Lewis; P J Hunt; P L Munns; W Hunter; D Baldwin
Journal:  N Z Med J       Date:  2002-05-10

2.  Maternal ginseng use associated with neonatal androgenization.

Authors:  G Koren; S Randor; S Martin; D Danneman
Journal:  JAMA       Date:  1990-12-12       Impact factor: 56.272

3.  Fulminant hepatic failure after herbal medicine ingestion in children.

Authors:  H Bagheri; P Broué; I Lacroix; D Larrey; J P Olives; P Vaysse; J Ghisolfi; J L Montastruc
Journal:  Therapie       Date:  1998 Jan-Feb       Impact factor: 2.070

4.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors:  C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

5.  Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea.

Authors:  M Roulet; R Laurini; L Rivier; A Calame
Journal:  J Pediatr       Date:  1988-03       Impact factor: 4.406

6.  Garlic burns.

Authors:  B Z Garty
Journal:  Pediatrics       Date:  1993-03       Impact factor: 7.124

7.  Profound neonatal congestive heart failure caused by maternal consumption of blue cohosh herbal medication.

Authors:  T K Jones; B M Lawson
Journal:  J Pediatr       Date:  1998-03       Impact factor: 4.406

Review 8.  Garlic burns.

Authors:  M Rafaat; A K Leung
Journal:  Pediatr Dermatol       Date:  2000 Nov-Dec       Impact factor: 1.588

9.  Acute hepatitis induced by kava kava.

Authors:  C L Humberston; J Akhtar; E P Krenzelok
Journal:  J Toxicol Clin Toxicol       Date:  2003

10.  Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.

Authors:  C A Haller; N L Benowitz
Journal:  N Engl J Med       Date:  2000-12-21       Impact factor: 176.079

View more
  3 in total

1.  RCT of the effect of berryfruit polyphenolic cultivar extract in mild steroid-naive asthma: a cross-over, placebo-controlled study.

Authors:  Sharon Power; Mathew Williams; Alex Semprini; Claire Munro; Rachel Caswell-Smith; Janine Pilcher; Mark Holliday; James Fingleton; Jacquie Harper; Roger Hurst; Mark Weatherall; Richard Beasley; Irene Braithwaite
Journal:  BMJ Open       Date:  2017-03-20       Impact factor: 2.692

2.  The paucity of ethical analysis in allergology.

Authors:  Jason Behrmann
Journal:  Allergy Asthma Clin Immunol       Date:  2013-02-07       Impact factor: 3.406

3.  Manifestations of food protein induced gastrointestinal allergies presenting to a single tertiary paediatric gastroenterology unit.

Authors:  Rosan Meyer; Catharine Fleming; Gloria Dominguez-Ortega; Keith Lindley; Louise Michaelis; Nikhil Thapar; Mamoun Elawad; Vijay Chakravarti; Adam T Fox; Neil Shah
Journal:  World Allergy Organ J       Date:  2013-08-06       Impact factor: 4.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.